IQVIA (IQV) Stock Analysis: AI Score & Alternative Data
IQV alt-data: revenue climbing, job postings lagging
Is IQVIA a buy right now? The alternative data says hold. This IQV stock analysis is built on the 25+ alternative data signals AltIndex tracks on IQVIA every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 59/100: a Hold. The stock trades at $241.99 with a $39B market cap.
The bullish side of the 90-day ledger: revenue up 8.4% YoY to $4.2B, web traffic up 22.9% to 1.4M monthly visits, and headcount (according to LinkedIn) up 9.7% to 85K employees. The drag: job postings down 71.1% to 1K open roles. That tension is what keeps the score mid-range.
IQV’s broader alt-data profile also covers business outlook (61% of employees positive), Facebook followers (71K), and sentiment (100/100). Every signal links to its own page with full history, the IQV technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on IQV is just below.
IQVIA AI Stock Analysis
IQVIA is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. At the core of its operations, IQVIA harnesses the power of data and technology to enable customers to deliver innovative treatments to patients faster and more efficiently.
Analysis generated August 3, 2026.
Recent IQVIA Stock Alerts
|
IQVIA | August 7 Over the past few months, there has been a noticeable downward trend in Job postings. |
|
IQVIA | August 6 Insider Alert: STAUB W RICHARD is selling shares |
|
IQVIA | August 2 Insider Alert: Sherbet Eric is selling shares |
|
IQVIA | July 30 Job postings are up by 27.3% in the last couple of days. |
IQVIA Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 1.4M | 22.9% | |
| Job Posts | 1K | 71.1% | |
| LinkedIn Employees | 85K | 9.7% | |
| Employee Recommend | 72 | 1.4% | |
| Business Outlook | 61 | 3.2% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 90.9% | |
| Stocktwits Mentions | 4 | 50.0% | |
| News Mentions | 1 | 75.0% | |
| Stocktwits Subscribers | 1K | 1.8% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 18K | 0% | |
| Instagram Followers | 34K | 7.0% | |
| Facebook Followers | 71K | 0% | |
| Facebook Engagement | 127 | 13.6% |
About IQVIA (IQV)
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
| Price | $241.99 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $39B |
| Year Range | $157 – $248 |
| Dividend Yield | 0% |
| PE Ratio | 28.9 |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest IQVIA News
View more →
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug DiscoveryAugust 4 - GlobeNewswire |
|
The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2August 4 - Yahoo Entertainment |
|
 |
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should KnowAugust 2 - Biztoc.com |
 |
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should KnowAugust 2 - Biztoc.com |
 |
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 BillionAugust 2 - Biztoc.com |
IQVIA Earnings & Financial Performance
View all earnings →IQVIA Insider Trading Activity
View all →| STAUB W RICHARD filed to sell 13,312 shares at $0.0. Aug 3 '26 |
| Patel Bhavik filed to sell 1,348 shares at $0.0. Jul 31 '26 |
| Cherofsky Keriann filed to sell 2,989 shares at $0.0. Jul 29 '26 |
| BOUSBIB ARI filed to sell 987,682 shares at $0.0. Jul 29 '26 |
| BOUSBIB ARI filed to sell 983,098 shares at $0.0. Jul 29 '26 |
IQVIA Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Kevin Hern |
Apr 6, 26 | Sell | $75K+ |
| Rob Bresnahan |
Jun 2, 25 | Sell | $8K+ |
| Rob Bresnahan |
May 8, 25 | Buy | $33K+ |
| Rob Bresnahan |
Mar 28, 25 | Sell | $8K+ |
| Rohit Khanna |
Jun 5, 24 | Sell | $8K+ |
Stocks Similar to IQVIA
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Revolution MedicinesRVMD |
$206.97 0.9% | $44B | 76 |
 |
Royalty PharmaRPRX |
$57.97 2.1% | $33B | 54 |
 |
BiogenBIIB |
$207.13 0.4% | $31B | 45 |
 |
Alnylam PharmaceuticalsALNY |
$216.98 1.0% | $29B | 65 |
 |
IlluminaILMN |
$191.79 2.0% | $28B | 51 |
Explore IQVIA Data
Frequently Asked Questions: IQVIA (IQV)
IQVIA has an AltIndex AI Score of 59/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
59/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of IQVIA (IQV) stock is $241.99 with a market cap of $39B.
As of today, IQVIA’s PE (Price to Earnings) ratio is 28.9.
View the latest IQVIA insider transactions to see recent buying and selling activity by company executives and directors.
Check the IQVIA congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The IQV stock price chart above shows IQVIA’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full IQVIA technical analysis for RSI, moving averages, and more.
See the stocks similar to IQVIA section on this page for companies in the same industry ranked by market cap and AI Score.
